Network-Based Machine Learning Approach to Predict Immunotherapy Response in Cancer Patients

The authors curated more than 700 immune checkpoint inhibitor (ICI)-treated patient samples with clinical outcomes and transcriptomic data, and observed that NetBio-based predictions accurately predicted ICI treatment responses in three different cancer types — melanoma, gastric cancer, and bladder cancer.